AEGERION PHARMACEUTICALS INC - NOTE 5.000% 4/0

Q4 2020 13F Holders as of 31 Dec 2020

Type / Class
Debt / NOTE 5.000% 4/0
Market price (% of par)
120.52%
Total 13F principal
$519,414
Principal change
-$60,196,980
Total reported market value
$626,000
Number of holders
1
Value change
-$72,445,856
Number of buys
1
Number of sells
5

Institutional Holders of AEGERION PHARMACEUTICALS INC - NOTE 5.000% 4/0 as of Q4 2020

As of 31 Dec 2020, AEGERION PHARMACEUTICALS INC - NOTE 5.000% 4/0 was held by 1 institutional bondholder reporting positions in Form 13F filings. These institutions reported holding $519,414 in principal (par value) of the bond. The largest 1 bondholders included Context Capital Management, LLC. This page lists 1 institutional bondholders reporting positions for the Q4 2020 filing period.
Investor Option Weight % Change % Value $ * Price (% of par) Principal Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.